Opinion
Video
Approaches to Patient Shared Decision-Making in EGFR-Mutated NSCLC
Panelists discuss how medical professionals use shared decision-making by aligning treatment options with patient values, discussing benefits, risks, and preferences. Patients often prioritize longest progression-free survival (PFS), lowest toxicity, and shortest infusion time. Collaborative discussions ensure personalized, evidence-based care.
Video content above is prompted by the following:
How do you incorporate shared decision-making when selecting the most appropriate initial treatment option for a patient and what do you find patients value most (eg, longest PFS, lowest toxicity, shortest infusion time commitment)?
Latest CME
View All
Video
Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina
Apr 17th 2025 - May 23rd 2025
online-activity
Video
Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota
Apr 17th 2025 - May 23rd 2025
online-activity
Video
18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
Apr 8th 2025 - May 14th 2025
online-activity
Related Content
.png?fit=crop&auto=format)
.jpg?fit=crop&auto=format)
